Category Health/Medical

Bypassing Broken Genes

New approach to gene therapy can correct any disease-causing mutation within a gene. A new approach to gene editing using the CRISPR/ Cas9 system bypasses disease-causing mutations in a gene, enabling treatment of genetic diseases linked to a single gene, such as cystic fibrosis, certain types of sickle cell anemia, and other rare diseases. The method, developed and tested in mice and human tissue cultures by researchers at Penn State, involves inserting a new, fully functional copy of the gene that displaces the mutated gene.

A proof-of-concept for the approach is described in a paper appearing online April 20 in the journal Molecular Therapy.

The CRISPR/Cas9 system has allowed promising new gene therapies that can target and correct disease-causing mutations in a gene...

Read More

Review summarizes known links between Endocrine Disruptors and Breast Cancer Risk

Exposure to certain endocrine-disrupting chemicals could elevate the risk of breast cancer, according to a new comprehensive systematic review of epidemiological research. However, for many chemicals, evidence is inconsistent or still limited. The review was carried out by researchers at the universities of Hong Kong and Eastern Finland and published in Critical Reviews in Food Science and Nutrition.

Endocrine-disrupting chemicals (EDCs) can interfere with the body’s hormonal system, also called the endocrine system, and are widely present in the environment. They originate from a variety of sources, including pesticides, plasticisers and other industrial and pharmaceutical chemicals, as well as natural sources...

Read More

‘Undruggable’ Cancer Protein becomes druggable, thanks to Shrub

jatropha-curcas
Curcusone D, the first synthesized BRAT-1 inhibitor, originally comes from the root of Jatropha curcas, a shrub native to the Americas. (Forest and Kim Starr)

A chemist from Purdue University has found a way to synthesize a compound to fight a previously “undruggable” cancer protein with benefits across a myriad of cancer types.

Inspired by a rare compound found in a shrub native to North America, Mingji Dai, professor of chemistry and a scientist at the Purdue University Center for Cancer Research, studied the compound and discovered a cost-effective and efficient way to synthesize it in the lab...

Read More

MicroMESH: A Microscopic Polymeric Network to attack Glioblastoma multiforme

The microMESH has the shape of a micrometric polymeric net, it is made with biodegradable materials and wraps around the tumor mass. Its structure consists of two separate compartments in which different drugs can be loaded which are released towards the tumor mass in an independent, precise, and prolonged fashion. The microMESH can ‘attack’ glioblastoma by combining different therapies: chemotherapy, nanomedicine, and immunotherapy.
CREDIT
D. Beghetto/IIT

A micro-sized polymeric net wrapping around brain tumors, just like a fishing net around a shoal of fish: this is microMESH, a new nanomedicine device capable of conforming around the surface of tumor masses and efficiently delivering drugs...

Read More